Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Institut Für Frauengesundheit GmbH
Sponsor

Institut Für Frauengesundheit GmbH

Germany Hindenburgstrasse 50, Innenstadt, 91054 Erlangen, Germany

About the sponsor

Research activity focuses on early breast cancer with hormone receptor positivity and HER2 negativity, particularly cases with a higher risk of recurrence and the need for closer long-term disease control.

  • Recurrence risk
  • Progression-free survival
  • Overall survival

The sponsor is also involved in studies examining treatment persistence and outcomes in patients receiving endocrine-based and targeted approaches for this disease setting.

About Specializations

Institut Für Frauengesundheit GmbH runs clinical trials in conditions such as Breast cancer, Hormone receptor positive HER2 negative breast cancer, Breast cancer female, Hormone receptor positive breast cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Breast cancer+1

Recruiting

Study of typology-based coaching and education to help patients with early hormone-positive HER2-negative breast cancer manage their treatment with ribociclib

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ribociclib
  • Sponsor:Institut Für Frauengesundheit GmbH

Hormone receptor positive breast cancer+2

Recruiting

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Institut Für Frauengesundheit GmbH

Breast cancer+4

Not recruiting

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Institut Für Frauengesundheit GmbH

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.